Antibiotic News and Research

RSS
Accelr8 reports $466,362 net sales revenue for first fiscal quarter ended October 31, 2010

Accelr8 reports $466,362 net sales revenue for first fiscal quarter ended October 31, 2010

Anacor Pharmaceuticals initiates AN2690 phase 3 program for onychomycosis fungal infection

Anacor Pharmaceuticals initiates AN2690 phase 3 program for onychomycosis fungal infection

Plasma technology safe, effective alternative to antibiotics to treat multi-drug resistant infections

Plasma technology safe, effective alternative to antibiotics to treat multi-drug resistant infections

Clinical trial investigates pomalidomide in only U.S. study for multiple myeloma

Clinical trial investigates pomalidomide in only U.S. study for multiple myeloma

Delphi places first stone of new building on Aéropole de Charleroi

Delphi places first stone of new building on Aéropole de Charleroi

Inimex, SARomics Biostructures achieve scientific milestone in IMX942 IDR collaboration

Inimex, SARomics Biostructures achieve scientific milestone in IMX942 IDR collaboration

Origin of Haiti cholera epidemic traced to South Asia

Origin of Haiti cholera epidemic traced to South Asia

Opinions: Questioning WHO's relevance; Reforming foreign aid; Efforts to prevent child marriage

Opinions: Questioning WHO's relevance; Reforming foreign aid; Efforts to prevent child marriage

Scientists determine 500 three-dimensional protein structures from bacterial and protozoan pathogens

Scientists determine 500 three-dimensional protein structures from bacterial and protozoan pathogens

Excreted antibiotics become potential sources of antibiotic resistant genes

Excreted antibiotics become potential sources of antibiotic resistant genes

St. Luke's Episcopal Hospital, UH College of Pharmacy earn national 'best practices' award

St. Luke's Episcopal Hospital, UH College of Pharmacy earn national 'best practices' award

Scientists work together to wipe out some of the most lethal diseases

Scientists work together to wipe out some of the most lethal diseases

Idis to manage ViroPharma's named patient program

Idis to manage ViroPharma's named patient program

Sequella files SQ109 IND for Phase 2 studies in H. pylori-related duodenal ulcers

Sequella files SQ109 IND for Phase 2 studies in H. pylori-related duodenal ulcers

Blocking quorum sensing would prevent bacteria from turning pathogenic

Blocking quorum sensing would prevent bacteria from turning pathogenic

NovaBay Pharmaceuticals, Galderma expand their multi-year collaboration agreement

NovaBay Pharmaceuticals, Galderma expand their multi-year collaboration agreement

Research on ribosome could aid antibiotic development against MRSA infection

Research on ribosome could aid antibiotic development against MRSA infection

St. Jude ICU honored with Beacon Award for Critical Care Excellence for second consecutive year

St. Jude ICU honored with Beacon Award for Critical Care Excellence for second consecutive year

FDA approves CUBICIN 2-minute IV injection for MRSA skin infections, bacteremia

FDA approves CUBICIN 2-minute IV injection for MRSA skin infections, bacteremia

Anacor, UCSF and NYBC collaborate to discover drug therapies for river blindness

Anacor, UCSF and NYBC collaborate to discover drug therapies for river blindness

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.